Mirtazapine 30mg Tablets

Manufacturer SUN Active Ingredient Mirtazapine Tablets(mir TAZ a peen) Pronunciation mir-TAZ-uh-peen
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)
🤰
Pregnancy Category
Category C
✅
FDA Approved
Oct 1996
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Mirtazapine is a medication used to treat depression. It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain, which can improve mood and reduce anxiety. It can also help with sleep and appetite.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. If this medication makes you sleepy, take it at bedtime. You can take it with or without food.

It's essential to continue taking this medication as directed by your doctor or healthcare provider, even if you start feeling well. Don't stop taking it without consulting your doctor first.

Storing and Disposing of Your Medication

To keep your medication effective and safe:

Store it at room temperature, away from light and moisture.
Keep it in a dry place, such as a closet or drawer.
Avoid storing it in a bathroom, where it may be exposed to heat and humidity.
Keep all medications in a safe and secure location, out of the reach of children and pets.
When you're finished with your medication or it expires, dispose of it properly. Don't flush it down the toilet or pour it down the drain unless you're instructed to do so by your pharmacist or healthcare provider.
Check with your pharmacist for guidance on the best way to dispose of your medication. You may also want to explore local drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Don't take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take Mirtazapine exactly as prescribed, usually once daily at bedtime due to its sedating effects.
  • Avoid alcohol and other CNS depressants (e.g., sleeping pills, pain medications) as they can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how this medication affects you.
  • Report any unusual changes in mood, behavior, or thoughts, especially suicidal thoughts, to your doctor immediately.
  • Do not stop taking Mirtazapine suddenly without consulting your doctor, as this can lead to withdrawal symptoms.
  • Monitor your weight, as weight gain can be a side effect.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 30 mg once daily at bedtime
Dose Range: 15 - 45 mg

Condition-Specific Dosing:

majorDepressiveDisorder: Initial dose 15 mg once daily at bedtime. Titrate gradually based on clinical response and tolerability, typically in increments of 15 mg, up to a maximum of 45 mg/day. Therapeutic effects may take 1-4 weeks to appear. The 30 mg dose is a common effective dose.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for major depressive disorder; use in pediatric patients is generally not recommended due to increased risk of suicidal thoughts and behaviors (Black Box Warning).
Adolescent: Not established for major depressive disorder; use in pediatric patients is generally not recommended due to increased risk of suicidal thoughts and behaviors (Black Box Warning).
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment needed for mild impairment (CrCl 50-80 mL/min).
Moderate: Consider a 30% reduction in dose (e.g., 15 mg daily) for moderate impairment (CrCl 10-50 mL/min).
Severe: Consider a 50% reduction in dose (e.g., 7.5 mg daily) for severe impairment (CrCl <10 mL/min).
Dialysis: Mirtazapine is not significantly removed by dialysis. Dose adjustment based on renal function is still necessary.

Hepatic Impairment:

Mild: No specific adjustment needed for mild impairment.
Moderate: Consider a 30% reduction in dose (e.g., 15 mg daily) for moderate impairment (Child-Pugh B).
Severe: Consider a 50% reduction in dose (e.g., 7.5 mg daily) for severe impairment (Child-Pugh C).

Pharmacology

đŸ”Ŧ

Mechanism of Action

Mirtazapine is a tetracyclic antidepressant that enhances central noradrenergic and serotonergic activity. It acts as an antagonist at central presynaptic alpha2-adrenergic autoreceptors and heteroreceptors, leading to an increase in norepinephrine and serotonin release. It is also a potent antagonist of 5-HT2 and 5-HT3 serotonin receptors, and H1 histamine receptors. Its antagonism of 5-HT2 and 5-HT3 receptors is thought to contribute to its antidepressant and anxiolytic effects, while H1 antagonism contributes to its sedative properties.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 50%
Tmax: Approximately 2 hours
FoodEffect: Food has a minimal effect on the rate and extent of absorption.

Distribution:

Vd: Approximately 2.5 L/kg
ProteinBinding: Approximately 85%
CnssPenetration: Yes

Elimination:

HalfLife: 20-40 hours (average 26 hours)
Clearance: Not available (highly variable)
ExcretionRoute: Primarily renal (approximately 75%) and fecal (approximately 15%)
Unchanged: <10%
âąī¸

Pharmacodynamics

OnsetOfAction: Sedative effects may be seen within days; antidepressant effects typically begin within 1-2 weeks, with full effect in 2-4 weeks.
PeakEffect: Antidepressant peak effect typically 2-4 weeks.
DurationOfAction: Approximately 24 hours (allows for once-daily dosing)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Mirtazapine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Trouble focusing
+ Memory problems
+ Feeling confused
+ Weakness
+ Seizures
+ Change in balance
Redness or irritation of the palms of hands or soles of feet
Flu-like symptoms
Mouth irritation or mouth sores
Restlessness
Fast or abnormal heartbeat
Severe dizziness or passing out
Joint pain

Serotonin Syndrome: A Potentially Life-Threatening Condition

There is a risk of developing serotonin syndrome, a severe and potentially deadly condition, especially when taking certain other medications. Seek medical help immediately if you experience:

Agitation
Change in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Sweating a lot
Severe diarrhea, upset stomach, or vomiting
Very bad headache

Severe Skin Reactions: Seek Medical Help Right Away

This medication may cause severe skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions. These conditions can be deadly and may also affect internal organs. Seek medical help immediately if you notice:

Red, swollen, blistered, or peeling skin
Red or irritated eyes
Sores in your mouth, throat, nose, eyes, genitals, or any areas of skin
Fever
Chills
Body aches
Shortness of breath
Swollen glands

Other Side Effects: Contact Your Doctor if Concerned

Like all medications, this drug may cause side effects. While many people experience no side effects or only minor ones, it's essential to contact your doctor if you're concerned about any of the following:

Feeling dizzy, sleepy, tired, or weak
Constipation
Dry mouth
Increased appetite
Weight gain
Strange or odd dreams

These are not all the possible side effects of this medication. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or suicidal thoughts/attempts
  • New or worsening anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (restlessness), hypomania, or mania
  • Symptoms of serotonin syndrome: agitation, hallucinations, confusion, fast heartbeat, fever, sweating, shivering, muscle stiffness or twitching, loss of coordination, nausea, vomiting, diarrhea
  • Signs of infection: fever, chills, sore throat, mouth sores, flu-like symptoms (rare, but can indicate agranulocytosis)
  • Severe skin rash, blistering, or peeling (rare, but can indicate Stevens-Johnson syndrome or toxic epidermal necrolysis)
  • Unexplained muscle pain, tenderness, or weakness (rare, but can indicate rhabdomyolysis)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
If you are currently taking or have recently taken certain medications, such as:
+ Anxiety or sleep aids like alprazolam or diazepam
+ Medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days, as this may increase the risk of very high blood pressure
+ Linezolid or methylene blue
* Other medications, including prescription and over-the-counter drugs, natural products, and vitamins, as this is not an exhaustive list of potential interactions

To ensure your safety, it is crucial to discuss all your medications and health problems with your doctor and pharmacist. They will help determine whether it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dosage of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Please note that it may take several weeks to experience the full effects of this drug.

To minimize the risk of side effects, do not abruptly stop taking this medication without consulting your doctor. If you need to discontinue this drug, your doctor will instruct you on how to gradually taper off the dosage to ensure a safe transition.

Until you are familiar with how this medication affects you, exercise caution when engaging in activities that require alertness, such as driving.

Certain individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication has been associated with rare cases of low white blood cell counts, which can increase the risk of infection. If you have a history of low white blood cell counts, inform your doctor. Be vigilant for signs of infection, such as fever, chills, or sore throat, and contact your doctor promptly if you experience any of these symptoms.

There is a risk of abnormal heart rhythms (long QT on ECG) associated with this medication, which can increase the risk of sudden death. Discuss this risk with your doctor.

Additionally, this medication may cause elevated cholesterol and triglyceride levels. Consult with your doctor to discuss the potential risks and benefits.

Regular blood tests will be necessary to monitor your condition. Adhere to your doctor's recommendations for blood work and follow their guidance.

It is recommended that you avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or any prescription or over-the-counter drugs that may cause drowsiness, consult with your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential benefits and risks with your doctor to ensure the best possible outcome for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Disorientation
  • Tachycardia (rapid heart rate)
  • Impaired consciousness
  • Mild to moderate respiratory depression
  • Hypotension

What to Do:

In case of suspected overdose, seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is generally supportive and symptomatic. There is no specific antidote.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (concurrent use or within 14 days of discontinuing MAOIs due to risk of serotonin syndrome)
🔴

Major Interactions

  • Other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, fentanyl, lithium, tramadol, St. John's Wort) - increased risk of serotonin syndrome.
  • CNS depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics) - additive CNS depression.
  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, cimetidine, protease inhibitors) - increased mirtazapine plasma concentrations.
  • CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin) - decreased mirtazapine plasma concentrations.
🟡

Moderate Interactions

  • Warfarin (minor increases in INR reported in some cases).
  • Drugs with anticholinergic properties (e.g., tricyclic antidepressants, antihistamines) - additive anticholinergic effects.
  • CYP1A2 inhibitors (e.g., ciprofloxacin) - potential for increased mirtazapine levels.
  • CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine) - potential for increased mirtazapine levels.
đŸŸĸ

Minor Interactions

  • Not many specific minor interactions; general caution with other medications.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Depression severity (e.g., HAM-D, PHQ-9)

Rationale: To establish baseline and monitor treatment response.

Timing: Prior to initiation

Suicidal ideation/behavior

Rationale: To assess baseline risk, especially in young adults.

Timing: Prior to initiation

Weight and BMI

Rationale: Mirtazapine can cause weight gain.

Timing: Prior to initiation

Blood pressure

Rationale: To assess baseline and monitor for orthostatic hypotension.

Timing: Prior to initiation

Liver function tests (LFTs)

Rationale: Mirtazapine is hepatically metabolized; baseline assessment is prudent.

Timing: Prior to initiation

Renal function (CrCl)

Rationale: Dose adjustment needed in renal impairment.

Timing: Prior to initiation

📊

Routine Monitoring

Depression severity and clinical response

Frequency: Weekly for first 4 weeks, then monthly or as clinically indicated

Target: Reduction in symptom scores, improved mood and functioning

Action Threshold: Lack of improvement or worsening symptoms may require dose adjustment or alternative therapy.

Suicidal ideation/behavior

Frequency: Especially during the initial few weeks of treatment and with dose changes; then regularly as clinically indicated.

Target: Absence of suicidal thoughts or behaviors

Action Threshold: Any emergence or worsening of suicidal thoughts/behaviors requires immediate clinical assessment and intervention.

Weight

Frequency: Monthly for first few months, then periodically

Target: Stable weight or acceptable weight gain

Action Threshold: Significant or undesirable weight gain may warrant dietary counseling or consideration of alternative therapy.

Blood pressure (especially orthostatic)

Frequency: Periodically, especially in elderly or those prone to hypotension

Target: Stable blood pressure, no significant orthostatic drop

Action Threshold: Symptomatic orthostatic hypotension may require dose reduction or intervention.

Adverse effects (e.g., sedation, dizziness, dry mouth, constipation)

Frequency: Regularly, especially during dose titration

Target: Tolerable side effect profile

Action Threshold: Intolerable side effects may require dose adjustment or discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence or worsening of suicidal thoughts or behavior
  • Unusual changes in behavior or mood (e.g., agitation, irritability, panic attacks, insomnia, impulsivity, hypomania, mania)
  • Symptoms of serotonin syndrome (e.g., agitation, hallucinations, delirium, tachycardia, labile blood pressure, hyperthermia, hyperreflexia, incoordination, nausea, vomiting, diarrhea)
  • Signs of infection (e.g., fever, sore throat, stomatitis, flu-like symptoms) which could indicate agranulocytosis (rare but serious adverse effect)
  • Severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis)

Special Patient Groups

🤰

Pregnancy

Category C. Mirtazapine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antidepressants in late third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding. These complications can arise immediately upon delivery.

Trimester-Specific Risks:

First Trimester: Limited human data, but animal studies show some developmental toxicity at high doses. Risk of major congenital malformations is generally low, but data are not conclusive.
Second Trimester: No specific data indicating unique risks during the second trimester.
Third Trimester: Potential for neonatal withdrawal symptoms (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypotonia, persistent pulmonary hypertension of the newborn) if exposed late in pregnancy.
🤱

Lactation

L3 (Moderately safe). Mirtazapine is excreted into breast milk in small amounts. The relative infant dose (RID) is low (estimated 1-2%). Monitor breastfed infants for sedation, poor feeding, and poor weight gain.

Infant Risk: Low to moderate. While generally considered compatible with breastfeeding, caution is advised. Monitor infant for drowsiness, irritability, poor feeding, and weight changes. Consult with a healthcare provider.
đŸ‘ļ

Pediatric Use

Not FDA approved for major depressive disorder in pediatric patients. A Black Box Warning exists regarding increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (ages 18-24) with MDD and other psychiatric disorders. Use in this population should be carefully considered and closely monitored.

👴

Geriatric Use

Start with a lower dose (e.g., 7.5 mg or 15 mg daily) and titrate slowly due to increased sensitivity to adverse effects (e.g., sedation, orthostatic hypotension) and potential for reduced renal and hepatic clearance. Monitor closely for falls, cognitive changes, and hyponatremia.

Clinical Information

💎

Clinical Pearls

  • Mirtazapine is often chosen for patients with depression who also experience significant insomnia, anxiety, or poor appetite/weight loss due to its sedating and appetite-stimulating properties.
  • The sedating effect is often more pronounced at lower doses (e.g., 15 mg) due to saturation of H1 receptors, while higher doses (e.g., 30-45 mg) may be less sedating as noradrenergic effects become more prominent.
  • Unlike many other antidepressants, mirtazapine has a low incidence of sexual dysfunction.
  • Weight gain is a common and often dose-limiting side effect.
  • Rare but serious adverse effects include agranulocytosis (monitor for signs of infection) and serotonin syndrome (especially with concomitant serotonergic agents).
🔄

Alternative Therapies

  • Selective Serotonin Reuptake Inhibitors (SSRIs) (e.g., fluoxetine, sertraline, escitalopram)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) (e.g., venlafaxine, duloxetine)
  • Atypical antidepressants (e.g., bupropion, vortioxetine, vilazodone)
  • Tricyclic Antidepressants (TCAs) (e.g., amitriptyline, nortriptyline)
  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., phenelzine, tranylcypromine - generally reserved for refractory cases)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy (CBT))
💰

Cost & Coverage

Average Cost: $20 - $100 per 30 tablets (generic 30mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.